Scientists from the A*STAR Genome Institute of Singapore (A*STAR GIS) have developed a new artificial intelligence (AI)-based method called “Fragle” that makes tracking cancer easier and faster using blood tests.
Requiring only a small blood sample, this method analyzes the size of DNA fragments in the blood to reveal distinct patterns that differentiate cancer DNA from healthy DNA, helping doctors track cancer treatment response more accurately and frequently. The research was published in Nature Biomedical Engineering in March 2025.
Existing methods for measuring cancer DNA in the blood, also known as circulating tumor DNA (ctDNA), often require complex and expensive DNA sequencing to screen for common cancer mutations. However, because cancer mutations vary between patients, test results can be inconsistent, making it difficult for doctors to track cancer treatment response with blood tests effectively.